Safety and Tolerability of SPD476 in Maintaining Remission in Patients With Ulcerative Colitis.
This study has been completed.
First Posted: September 9, 2005
Last Update Posted: June 9, 2014
Information provided by:
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||October 2006|
|Primary Completion Date:||No date given|
Kamm MA, Lichtenstein GR, Sandborn WJ, Schreiber S, Lees K, Barrett K, Joseph R. Randomised trial of once- or twice-daily MMX mesalazine for maintenance of remission in ulcerative colitis. Gut. 2008 Jul;57(7):893-902. doi: 10.1136/gut.2007.138248. Epub 2008 Feb 13.